US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
WASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration targeting industry practices that drive up pharmaceutical prices.
The Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other reparatory conditions. The letters allege that certain patents filed by Novo Nordisk, GlaxoSmithKline, AstraZeneca and seven other companies are inaccurate or misleading.
Brand-name drugmakers use patents to protect their medicines and stave off cheaper, generic medicines. Most blockbuster drugs are protected by dozens of patents covering various ingredients, manufacturing processes and intellectual property. Generic drugmakers can only launch their own cheaper versions if the patents have expired or are successfully challenged in court.
Related articles
‘The Blue Angels,’ filmed for IMAX, puts viewers in the ‘box’ with the elite flying squad
If you’re looking for a little bit of that “ Top Gun: Maverick ” spectacle and thrill at the movie t2024-05-21World Wetlands Day: A glimpse of China's earth’s kidneys
Feb. 2, 2021 marks the World Wetlands Day, themed “Wetland and Water.” The wetland resource, known a2024-05-21Village benefits from ecological improvement of Erhai Lake in Yunnan
Aerial photo taken on Sept. 14, 2020 shows the view of Gusheng Village in Dali, southwest China's Yu2024-05-21Scenery of Minjiang River estuary wetland in Fuzhou
A flock of black-faced spoonbills are seen at the Minjiang River estuary wetland in Fuzhou, southeas2024-05-21Why US Catholics are planning pilgrimages in communities across the nation
A long-planned series of Catholic pilgrimages has begun across the United States this weekend, with2024-05-21Light show held in Haikou, S China
People watch a light show around a bell tower in Haikou, south China's Hainan Province, Feb. 19, 2022024-05-21
atest comment